Comparison - ADXN - NASDAQ

Weiss Ratings	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Fair
Risk Index	Weak
Risk Grade	D-
Reward Grade	C

Rating Factors	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Weak
Efficiency Index	Good
Solvency Index	Excellent
Total Return Index	Very Weak
Volatility Index	Weak

Beta / Standard Deviation	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	1.22

Price History	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-2.67%
30-Day Total Return	-6.41%
60-Day Total Return	-8.52%
90-Day Total Return	-1.08%
Year to Date Total Return	-3.19%
1-Year Total Return	-52.61%
2-Year Total Return	-63.27%
3-Year Total Return	-92.43%
5-Year Total Return	-94.59%
52-Week High % Change	-73.30%
52-Week Low % Change	11.69%

Price	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$27.90
52-Week Low Price	$6.67
52-Week Low Price (Date)	Feb 19, 2025
52-Week High Price (Date)	Apr 09, 2024

Valuation	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	5.68M
Enterprise Value	1.94M
Price/Earnings (TTM)	154.89
Earnings Per Share (TTM)	0.05
Earnings Per Share Growth	-124.97%
Price/Earnings To Growth	--
Price/Sales (TTM)	1,095.59
Price/Book (Q)	55.93
Enterprise Value/Revenue (TTM)	2.89
Price	$7.30
Enterprise Value/EBITDA (TTM)	-0.36
Enterprise Value/EBIT	-0.34
Market Cap Category	Nano Cap

Dividends and Shares	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	98.30M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	41 22 884 1555
Address	--
Website	www.addextherapeutics.com
Country	Switzerland
Year Founded	2002

Profitability	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-840.86%
Profit Margin	851.42%

Management Effectiveness	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-33.41%
Return on Equity	--

Income Statement	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	630.00K
Total Revenue (TTM)	671.30K
Revenue Per Share	$0.01
Gross Profit (TTM)	-1.97M
EBITDA (TTM)	-5.45M
EBIT (TTM)	-5.64M
Net Income (TTM)	5.72M
Net Income Avl. to Common (TTM)	5.72M
Total Revenue Growth (Q YOY)	-81.89%
Earnings Growth (Q YOY)	-119.47%
EPS Diluted (TTM)	0.05
EPS Diluted Growth (Q YOY)	40.97%

Balance Sheet	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	3.96M
Cash Per Share (Q)	$0.04
Total Current Assets (Q)	4.82M
Total Preferred Equity (Q)	--
Total Equity (Q)	13.10M
Current Ratio (Q)	4.588
Book Value Per Share (Q)	$0.13
Total Assets (Q)	14.41M
Total Current Liabilities (Q)	1.05M
Total Debt (Q)	51.80K
Total Liabilities (Q)	1.31M
Total Common Equity (Q)	13.10M

Cash Flow	ADXN - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	5.15M
Cash from Financing (TTM)	58.20K
Net Change in Cash (TTM)	-1.68M
Levered Free Cash Flow (TTM)	-2.85M
Cash from Operations (TTM)	-6.72M